Japan's bold experiment to curb antibiotic misuse has been a huge success. Could it work in the US?

Key Points:

• About a decade ago, Japan identified excessive and inappropriate antibiotic prescriptions by pediatricians, especially broad-spectrum antibiotics for viral infections in children under 3, fueling antimicrobial resistance (AMR).
• To combat this, Japan introduced a financial incentive in 2018, paying pediatricians approximately $5 per case when they appropriately withheld antibiotics for likely viral infections, encouraging better prescribing practices.
• The incentive program led to a nearly 45% reduction in antibiotic prescriptions within the first month among eligible clinics and sustained reductions of 20-24% over four years without increasing hospitalizations or healthcare costs.
• The program has expanded to include more age groups, specialists like ENT doctors, and additional conditions, with complementary incentives rewarding clinics for higher use of narrow-spectrum antibiotics.
• Experts view Japan’s incentive-based approach as a cost-effective and culturally accepted strategy to reduce AMR, raising questions about whether similar programs could be effective in other countries, including the U.S.